CAJ | 학술논문

目的修订多发性硬化患者生存质量量表-54(MSQOL-54),检验该量表的信度和效度.方法 1.对源量表进行翻译和回译,再进行文化调适和预测试;2.通过对30例多发性硬化患者的生存质量进行测评,检验多发性硬化患者生存质量量表中文版的信度和效度.结果多发性硬化患者生存质量量表中文版的信度检验显示量表总分和其13个方面的重测相关系数大于0.7;量表总分和12个方面的Cronbach 系数都大于0.7,分半信度为0.96;因子分析结果提示该量表的结构效度好;除认知方面外,其他方面与总分显著相关(r=0.40～0.84);该量表与SF-36的效标效度为0.98;患者与正常人该量表得分比较,除了性功能和对性功能的满意度方面外,其他方面得分有显著差异.结论多发性硬化患者生存质量量表-54中文版的信度、效度较好,达到了心理测量学的要求,适合我国多发性硬化患者的生存质量评价.
목적 수정다발성경화환자생존질량량표-54(MSQOL-54),검험해량표적신도화효도.방법 1.대원량표진행번역화회역,재진행문화조괄화예측시;2.통과대30례다발성경화환자적생존질량진행측평,검험다발성경화환자생존질량량표중문판적신도화효도.결과 다발성경화환자생존질량량표중문판적신도검험현시량표총분화기13개방면적중측상관계수대우0.7;량표총분화12개방면적Cronbach 계수도대우0.7,분반신도위0.96;인자분석결과제시해량표적결구효도호;제인지방면외,기타방면여총분현저상관(r=0.40～0.84);해량표여SF-36적효표효도위0.98;환자여정상인해량표득분비교,제료성공능화대성공능적만의도방면외,기타방면득분유현저차이.결론 다발성경화환자생존질량량표-54중문판적신도、효도교호,체도료심리측량학적요구,괄합아국다발성경화환자적생존질량평개.
Objective To translate and adapt the multiple sclerosis quality of life-54 questionnaire and evaluate the reliability and validity of this scale. Methods Using translation, back-translation, cross-cultural adaptation and protest we got the adaptation of the scale.Thirty multiple sclerosis patients were examined by the Chinese version of the scale, and their data were used to evaluate reliability and validity of the scale. Results The evaluation of the reliability of the scale showed the test-retest correlation coefficients of total scale and 13 aspects were above 0.7, the Cronbach of total scales and 12 aspects were above 0.7, the split-half coefficients was 0.96.The evaluation of validity of this scale showed the construct validity was good as indicated by factor analysis.Except health perceptions aspect, other aspects showed significant correlation to total scale(r =0.40～0.84);the correlation coefficient of criteria validity was 0.98.Except sexual function and satisfaction with sexual function aspects, there were statistical differences in aspect scores of this scale between multiple sclerosis patients and normal persons. Conclusion The reliability and validity of Chinese version of the multiple sclerosis quality of life-54 questionnaire are good enough for meeting psychometric standard, and can be applied to assess quality of life for patients with multiple sclerosis in China.